Document Detail


Management studies using a combination of D-dimer test result and clinical probability to rule out venous thromboembolism: a systematic review.
MedLine Citation:
PMID:  16150049     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: While the number of patients with suspected venous thromboembolism (VTE) referred to hospital emergency units increases, the proportion in whom the diagnosis can be confirmed is decreasing. A more efficient but safe diagnostic strategy is needed. OBJECTIVE: To evaluate the safety of withholding anticoagulant therapy in patients suspected of VTE based on a diagnostic work-up that combines a clinical decision rule (CDR) with a D-dimer test result without performing additional diagnostic tests. PATIENTS/METHODS: We searched Medline (January 1996-December 2004)-related articles and reference lists of studies in English for prospective clinical studies that managed consecutive patients suspected of VTE and used a D-dimer assay combined with an explicit CDR or implicit clinical judgment. RESULTS: We identified 11 studies in which 6837 consecutive outpatients suspected of VTE were included. In the combined management studies, the overall rate of thromboembolic events was nine out of 2056 patients (0.44 %, 95% CI 0.2%-0.83%) in whom anticoagulants were withheld based on the D-dimer result and a low clinical score. Similar results were obtained with qualitative and quantitative D-dimer tests and with different decision rules. The rate of exclusion varied between 30% and 50% and was highest with a low incidence of VTE among those referred. CONCLUSION: Withholding anticoagulant treatment in patients suspected of VTE on the basis of a work-up consisting of a low clinical probability combined with either a qualitative or quantitative D-dimer test result is safe.
Authors:
A J Ten Cate-Hoek; M H Prins
Related Documents :
20651889 - catheter in the superior vena cava for hemodialysis as a last resort in superior hemith...
10990549 - Upper extremity deep venous thrombosis: an underrecognized manifestation of a hypercoag...
9342969 - Prethrombotic state due to hypercoagulability in patients with permanent transvenous pa...
3516589 - Role of surgery in iliofemoral venous thrombosis.
10440939 - Selection of appropriate venous access for the collection of peripheral blood progenito...
12100159 - Factor v leiden in central venous catheter-associated thrombosis.
7733199 - Electrophysiologic abnormalities in two cases of familial amyloidosis.
17652219 - Patients with mutations in gsalpha have reduced activation of a downstream target in ep...
3113959 - Intestinal accumulation of 111in-granulocytes in patients studied because of occult inf...
Publication Detail:
Type:  Journal Article; Review     Date:  2005-09-09
Journal Detail:
Title:  Journal of thrombosis and haemostasis : JTH     Volume:  3     ISSN:  1538-7933     ISO Abbreviation:  J. Thromb. Haemost.     Publication Date:  2005 Nov 
Date Detail:
Created Date:  2005-10-24     Completed Date:  2006-04-27     Revised Date:  2006-11-07    
Medline Journal Info:
Nlm Unique ID:  101170508     Medline TA:  J Thromb Haemost     Country:  England    
Other Details:
Languages:  eng     Pagination:  2465-70     Citation Subset:  IM    
Affiliation:
Division of Hematology, Academic Hospital Maastricht, Maastricht, the Netherlands. ahoek@lhle.azm.nl
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Decision Support Techniques*
Disease Management
Fibrin Fibrinogen Degradation Products / analysis*
Humans
Incidence
MEDLINE
Outpatients
Predictive Value of Tests
Prospective Studies
Thromboembolism / blood,  diagnosis*,  epidemiology
Venous Thrombosis / blood,  diagnosis*,  epidemiology
Chemical
Reg. No./Substance:
0/Fibrin Fibrinogen Degradation Products; 0/fibrin fragment D

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Activation of platelets by heparin-induced thrombocytopenia antibodies in the serotonin release assa...
Next Document:  Cyclooxygenase-1 haplotype modulates platelet response to aspirin.